FDX1 and hepatocellular carcinoma: Furthermore, the cytotoxicity was specifically reversed by the cuproptosis inhibitor TTM, but not by ferroptosis or apoptosis inhibitors, confirming the specificity of the death pathway.<h4>Conclusion</h4>Our findings demonstrate that emodin triggers cuproptosis in HCC via the SLC7A11/FDX1 axis.